Brief: Orphazyme Announces Update On Regulatory Review Of Arimoclomol In The European Union

Strategic Partners A/S

23/02/2022 22:23

Feb 23 (Reuters) - Orphazyme A/S  ORPHA.CO :
    * ORPHAZYME ANNOUNCES UPDATE ON REGULATORY REVIEW OF
ARIMOCLOMOL
IN THE EUROPEAN UNION
    * ORPHAZYME A/S - HAS BEEN NOTIFIED BY CHMP OF A NEGATIVE
TREND
VOTE ON MAA FOR ARIMOCLOMOL IN NPC FOLLOWING AN ORAL EXPLANATION
    * ORPHAZYME A/S - TREND VOTE INDICATES THAT CHMP'S CURRENT
ORIENTATION IS TO NOT APPROVE ARIMOCLOMOL WHEN IT CONVENES BY
END OF MARCH 2022
    * ORPHAZYME A/S - CONSIDERS IT UNLIKELY THAT CHMP'S POSITION
WILL
CHANGE BEFORE FORMAL VOTE IS UNDERTAKEN NEXT MONTH
    * ORPHAZYME A/S - COMPANY WILL NOW ASSESS COMPANY'S
STRATEGIC
OPTIONS AND PROVIDE AN UPDATE TO MARKET AT APPLICABLE TIME

Source text for Eikon:  ID:nGNX3Ppbgj 
Further company coverage:  ORPHA.CO 

 ((Reuters.Briefs@thomsonreuters.com;))